Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

WHO says global rise in COVID cases is 'tip of the iceberg'

Published 03/16/2022, 12:45 PM
Updated 03/17/2022, 02:41 AM
© Reuters. FILE PHOTO: Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), attends a news conference in Geneva, Switzerland, December 20, 2021. REUTERS/Denis Balibouse

By Jennifer Rigby and Manas Mishra

(Reuters) - Figures showing a global rise in COVID-19 cases could herald a much bigger problem as some countries also report a drop in testing rates, the WHO said on Tuesday, warning nations to remain vigilant against the virus.

After more than a month of decline, COVID cases started to increase around the world last week, the WHO said, with lockdowns in Asia and China's Jilin province battling to contain an outbreak.

A combination of factors was causing the increases, including the highly transmissible Omicron variant and its cousin the BA.2 sub-variant, and the lifting of public health and social measures, the WHO said.

"These increase are occurring despite reductions in testing in some countries, which means the cases we're seeing are just the tip of the iceberg," WHO's head Tedros Adhanom Ghebreyesus told reporters.

Low vaccination rates in some countries, driven partly by a "huge amount of misinformation" also explained the rise, WHO officials said.

New infections jumped by 8% globally compared to the previous week, with 11 million new cases and just over 43,000 new deaths reported from March 7-13. It is the first rise since the end of January.

The biggest jump was in the WHO’s Western Pacific region, which includes South Korea and China, where cases rose by 25% and deaths by 27%.

Africa also saw a 12% rise in new cases and 14% rise in deaths, and Europe a 2% rise in cases but no jump in deaths. Other regions reported declining cases, including the eastern Mediterranean region, although this area saw a 38% rise in deaths linked to a previous spike in infections.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A number of experts have raised concerns that Europe faces another coronavirus wave, with case rising since the beginning of March in Austria, Germany, Switzerland, the Netherlands, and the United Kingdom.

The WHO's Maria Van Kerkhove said at the briefing that BA.2 appears to be the most transmissible variant so far.

However, there are no signs that it causes more severe disease, and no evidence that any other new variants are driving the rise in cases.

The picture in Europe is also not universal. Denmark, for example, saw a brief peak in cases in the first half of February, driven by BA.2, which quickly subsided.

But experts have begun to warn that the United States could soon see a similar wave to that seen in Europe, potentially driven by BA.2, the lifting of restrictions and potential waning immunity from vaccines given several months ago.

"I agree with the easing of restrictions, because you can't think of it as an emergency after two years," said Antonella Viola, professor of immunology at Italy's University of Padua.

"We just have to avoid thinking that COVID is no longer there. And therefore maintain the strictly necessary measures, which are essentially the continuous monitoring and tracking of cases, and the maintenance of the obligation to wear a mask in closed or very crowded places."

Latest comments

Who is not credible. bought and paid for by corporations and china. On the same level as Fauci!
If the vaccines based on old proven technologies were simply approved for use (they've already passed phase 3 trials but are being held up by pressure from big pharma and pressure from people like Fauci who are also bought and paid for) then we'd see a real honest reduction in cases from real proven vaccines instead of the mRNA fraud.
we are vaccinated and boosted, to the rest, good luck!
it mutates and spreads too quickly for them to be easily able to pivot the formula. By the time the public gets it, after trials, it's no longer needed as there's a new strain and it may or may not be effective against it which requires more trials and more money flushed down the toilet. If you don't understand the tech, fine... sorry for you.
Thank you for being our Guinea Pigs. Truly, we are thankful. We understand MRNA could be the future, its just us logical people understand the necessity for fully completed trials to make a decision. BTW, current MRNA Covid vaccines are still in trial phase until 2024. You are a literal guinea **** in case youre unaware. Good luck
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.